An exploratory, randomized, double-blind, placebo controlled study to assess the efficacy of multiple doses of omalizumab in cystic fibrosis complicated with allergic bronchopulmonary aspergillosis An exploratory, randomized, double-blind, placebo controlled study to assess the efficacy of multipl ...
An exploratory, randomized, double-blind, placebo controlled study to assess the efficacy of multiple doses of omalizumab in cystic fibrosis complicated with allergic bronchopulmonary aspergillosis An exploratory, randomized, double-blind, placebo controlled study to assess the efficacy of multipl ...
Patients with cystic fibrosis complicated by allergic bronchopulmonary aspergillosis. MedDRA version: 9.1;Level: LLT;Classification code 10011763;Term: Cystic fibrosis lung MedDRA version: 9.1;Classification code 10000244;Term: ABPA Patients with cystic fibrosis complicated by allergic bronchopulmonary aspergillosis. MedDRA version ...
Trade Name: Xolair 150 mg Pulver und Injektionslösung zur Herstellung einer Injektionslösung Product Name: Xolair Product Code: IGE025 INN or Proposed INN: Omalizumab Trade Name: Xolair 150 mg Pulver und Injektionslösung zur Herstellung einer Injektionslösung Product ...
Novartis Pharma Services AG
NULL
Not Recruiting
Female: yes Male: yes
60
United Kingdom;Germany;Netherlands;Belgium;Ireland;Italy